Annual CFF
$1.23 B
+$927.77 M+307.79%
December 31, 2023
Summary
- As of February 11, 2025, RVMD annual cash flow from financing activities is $1.23 billion, with the most recent change of +$927.77 million (+307.79%) on December 31, 2023.
- During the last 3 years, RVMD annual CFF has risen by +$806.42 million (+190.74%).
- RVMD annual CFF is now at all-time high.
Performance
RVMD Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$77.29 M
+$69.79 M+930.04%
September 30, 2024
Summary
- As of February 11, 2025, RVMD quarterly cash flow from financing activities is $77.29 million, with the most recent change of +$69.79 million (+930.04%) on September 30, 2024.
- Over the past year, RVMD quarterly CFF has increased by +$76.48 million (+9442.47%).
- RVMD quarterly CFF is now -90.79% below its all-time high of $839.35 million, reached on December 31, 2023.
Performance
RVMD Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$924.96 M
+$76.28 M+8.99%
September 30, 2024
Summary
- As of February 11, 2025, RVMD TTM cash flow from financing activities is $924.96 million, with the most recent change of +$76.28 million (+8.99%) on September 30, 2024.
- Over the past year, RVMD TTM CFF has increased by +$19.16 million (+2.11%).
- RVMD TTM CFF is now -24.75% below its all-time high of $1.23 billion, reached on December 31, 2023.
Performance
RVMD TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
RVMD Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +307.8% | +9442.5% | +2.1% |
| 3 y3 years | +190.7% | +10000.0% | +224.6% |
| 5 y5 years | +1920.2% | +5105.0% | +118.8% |
RVMD Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +317.8% | -90.8% | >+9999.0% | -24.8% | +7469.3% |
| 5 y | 5-year | at high | +1145.9% | -90.8% | +5138.7% | -24.8% | +7469.3% |
| alltime | all time | at high | +5324.1% | -90.8% | +5138.7% | -24.8% | >+9999.0% |
Revolution Medicines Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $77.29 M(+930.0%) | $924.96 M(+9.0%) |
| Jun 2024 | - | $7.50 M(+826.4%) | $848.68 M(-6.3%) |
| Mar 2024 | - | $810.00 K(-99.9%) | $905.80 M(-26.3%) |
| Dec 2023 | $1.23 B(+307.8%) | $839.35 M(>+9900.0%) | $1.23 B(+178.6%) |
| Sep 2023 | - | $1.01 M(-98.4%) | $441.21 M(-35.9%) |
| Jun 2023 | - | $64.63 M(-80.1%) | $688.53 M(+10.1%) |
| Mar 2023 | - | $324.20 M(+531.2%) | $625.33 M(+107.5%) |
| Dec 2022 | $301.43 M(+2.5%) | $51.36 M(-79.3%) | $301.43 M(+15.6%) |
| Sep 2022 | - | $248.34 M(>+9900.0%) | $260.80 M(+1940.5%) |
| Jun 2022 | - | $1.43 M(+368.5%) | $12.78 M(+4.6%) |
| Mar 2022 | - | $305.00 K(-97.2%) | $12.22 M(-95.8%) |
| Dec 2021 | $294.18 M | $10.73 M(+3263.0%) | $294.18 M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $319.00 K(-63.2%) | $284.94 M(-37.2%) |
| Jun 2021 | - | $868.00 K(-99.7%) | $453.50 M(+0.5%) |
| Mar 2021 | - | $282.26 M(>+9900.0%) | $451.30 M(+6.7%) |
| Dec 2020 | $422.78 M(+328.5%) | $1.49 M(-99.1%) | $422.78 M(+0.7%) |
| Sep 2020 | - | $168.88 M(<-9900.0%) | $419.76 M(+60.9%) |
| Jun 2020 | - | -$1.34 M(-100.5%) | $260.88 M(-26.0%) |
| Mar 2020 | - | $253.74 M(<-9900.0%) | $352.39 M(+257.2%) |
| Dec 2019 | $98.66 M(+62.1%) | -$1.53 M(-115.3%) | $98.66 M(-1.5%) |
| Sep 2019 | - | $10.01 M(-88.9%) | $100.19 M(+11.1%) |
| Jun 2019 | - | $90.17 M(>+9900.0%) | $90.19 M(>+9900.0%) |
| Mar 2019 | - | $14.00 K | $14.00 K |
| Dec 2018 | $60.85 M(+168.5%) | - | - |
| Dec 2017 | $22.66 M | - | - |
FAQ
- What is Revolution Medicines annual cash flow from financing activities?
- What is the all time high annual CFF for Revolution Medicines?
- What is Revolution Medicines annual CFF year-on-year change?
- What is Revolution Medicines quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Revolution Medicines?
- What is Revolution Medicines quarterly CFF year-on-year change?
- What is Revolution Medicines TTM cash flow from financing activities?
- What is the all time high TTM CFF for Revolution Medicines?
- What is Revolution Medicines TTM CFF year-on-year change?
What is Revolution Medicines annual cash flow from financing activities?
The current annual CFF of RVMD is $1.23 B
What is the all time high annual CFF for Revolution Medicines?
Revolution Medicines all-time high annual cash flow from financing activities is $1.23 B
What is Revolution Medicines annual CFF year-on-year change?
Over the past year, RVMD annual cash flow from financing activities has changed by +$927.77 M (+307.79%)
What is Revolution Medicines quarterly cash flow from financing activities?
The current quarterly CFF of RVMD is $77.29 M
What is the all time high quarterly CFF for Revolution Medicines?
Revolution Medicines all-time high quarterly cash flow from financing activities is $839.35 M
What is Revolution Medicines quarterly CFF year-on-year change?
Over the past year, RVMD quarterly cash flow from financing activities has changed by +$76.48 M (+9442.47%)
What is Revolution Medicines TTM cash flow from financing activities?
The current TTM CFF of RVMD is $924.96 M
What is the all time high TTM CFF for Revolution Medicines?
Revolution Medicines all-time high TTM cash flow from financing activities is $1.23 B
What is Revolution Medicines TTM CFF year-on-year change?
Over the past year, RVMD TTM cash flow from financing activities has changed by +$19.16 M (+2.11%)